Editorial comment

• Urban green spaces and cardiovascular health: from landscape to clinical impact

  Julia Playán-Escribano, Inés Ramos González-Cristóbal, Adolfo Villa

  Rev Esp Cardiol. 2026;79:520-1

• Consolidating the role of SGLT2 inhibitors in patients undergoing transcatheter aortic valve implantation

  Pablo Domínguez-Erquicia, Sergio Raposeiras-Roubín

  Rev Esp Cardiol. 2026;79:508-9

• Dilated cardiomyopathy: beyond a one-size-fits-all approach

  Irene Marco, Josebe Goirigolzarri-Artaza, María Alejandra Restrepo-Córdoba

  Rev Esp Cardiol. 2026;79:430-2

• Clinical impact of ACURATE valvular prosthesis underexpansion. Myth or reality?

  Won-Keun Kim, Stefan Toggweiler

  Rev Esp Cardiol. 2026;79:406-7

• The invisible threat: air pollution is now the second leading risk factor for mortality in the general population

  Alberto Domínguez-Rodríguez, Daniel Hernández-Vaquero, Néstor Baéz-Ferrer

  Rev Esp Cardiol. 2026;79:128-30

• Fewer stents for STEMI. Are DCBs ready for prime time?

  Bruno Scheller

  Rev Esp Cardiol. 2026;79:106-7

• Shaping prognosis in severe tricuspid regurgitation via right ventricular-pulmonary arterial coupling assessment

  Dalila Nappa, Rocío Hinojar, Covadonga Fernández-Golfín

  Rev Esp Cardiol. 2026;79:46-8

• Increased cardiovascular mortality in people with disabilities. A challenge that must be addressed

  Pedro Armario, Montserrat Martín-Baranera

  Rev Esp Cardiol. 2026;79:13-4

• Registries of the Heart Rhythm Association of the Spanish Society of Cardiology: current role and future prospects

  David Calvo

  Rev Esp Cardiol. 2025;78:1113-4

• Etiological diagnosis of myocarditis: an unresolved issue?

  Fernando Domínguez

  Rev Esp Cardiol. 2025;78:1118-9

• Refining the assessment of excessive left ventricular trabeculation

  Álvaro Montes Muñiz, Alberto Cecconi, Luis Jesús Jiménez-Borreguero

  Rev Esp Cardiol. 2025;78:945-6

• Refractory congestion in heart failure: when standard therapies fall short

  Rafael de la Espriella

  Rev Esp Cardiol. 2025;78:1007-9

• From the stethoscope to artificial intelligence: decoding tricuspid disease

  Covadonga Fernández-Golfín, Ana García-Martín

  Rev Esp Cardiol. 2025;78:848-9

• Prognostic benefit of percutaneous revascularization for chronic total coronary occlusions. Paradoxes and contradictions in an endless debate

  Alfonso Jurado-Román, José M. Montero-Cabezas

  Rev Esp Cardiol. 2025;78:860-2

• Atrial fibrillation and myocardial infarction: a bidirectional relationship with more questions than answers

  Alfredo Bardají, Gabriel Martín, Sandra Cabrera

  Rev Esp Cardiol. 2025;78:765-7

• “If you search for it, you’ll find it”: lessons from the Spanish cohort of the p.Val142Ile amyloidosis variant

  Roberto Barriales-Villa, Esteban Martín-Álvarez, José M. Larrañaga-Moreira

  Rev Esp Cardiol. 2025;78:778-9

• Antithrombotic therapy after percutaneous left atrial appendage closure: should it be the same for everyone?

  Daniel Tébar-Márquez, Alejandro Díez-Vidal, Yale Tung-Chen

  Rev Esp Cardiol. 2025;78:679-81

• Vessel tortuosity: the understudied factor in percutaneous coronary intervention

  Íñigo Lozano, Ramón López-Palop, José Ramón Rumoroso

  Rev Esp Cardiol. 2025;78:692-3

• The Cardiovascular Health Strategy of the National Health System (ESCAV). A great opportunity and responsibility for all

  Luis Rodríguez Padial, Julián Pérez Villacastín

  Rev Esp Cardiol. 2025;78:637-8

• Antiplatelet therapy for primary prevention of nonsignificant coronary lesions

  Jose Antonio Esteban-Chapel, Juan Antonio Franco-Peláez, Alvaro Aceña

  Rev Esp Cardiol. 2025;78:590-1